Following our observation that links c-Myc with SCD-1 as a potential survival mechanism, we could speculate that targeting stearoyl CoA desaturase 1 as a novel therapeutic target is of particular relevance given the possibility of using SCD-1 inhibitors [50] in combination with Myc therapies to reduce tumor growth. The gene discussed is MYC; the disease is neoplasm.